Synthesis of Quinazoline Analogues with Differential Activity for HER2-overexpressing Breast Cancer Cells

被引：1

作者：

Jang, Sun-Young ^{[1
,2
]}

Lee, Seul ^{[2
]}

Kim, Mira ^{[1
,2
]}

Ham, Young Jin ^{[1
]}

Cha, Mi Young ^{[1
]}

Suh, Kwee Hyun ^{[1
]}

Kim, Young Hoon ^{[1
]}

Kwon, Ara ^{[2
]}

Kang, Hae Ju ^{[2
]}

Min, Kyung Hoon ^{[2
]}

Lee, Kwang-Ok ^{[1
]}

机构：

[1] Hanmi Pharm Co Ltd, Hanmi Res Ctr, Gyeonggi Do 445813, South Korea

[2] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea

来源：

BULLETIN OF THE KOREAN CHEMICAL SOCIETY | 2015年 / 36卷 / 07期

关键词：

HER2; Tyrosine kinase inhibitor; Quinazoline analogues; TYROSINE KINASE-ACTIVITY; NEU ONCOGENE; LAPATINIB; MUTATIONS; RECEPTOR; GENE;

D O I：

10.1002/bkcs.10358

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

[No abstract available]

引用

页码：1933 / 1935

页数：3

共 14 条

[1] THE PRODUCT OF THE HUMAN C-ERBB-2 GENE - A 185-KILODALTON GLYCOPROTEIN WITH TYROSINE KINASE-ACTIVITY [J].

AKIYAMA, T ;

SUDO, C ;

OGAWARA, H ;

TOYOSHIMA, K ;

YAMAMOTO, T .

SCIENCE, 1986, 232 (4758) :1644-1646

[2] THE NEU ONCOGENE ENCODES AN EPIDERMAL GROWTH-FACTOR RECEPTOR-RELATED PROTEIN [J].

BARGMANN, CI ;

HUNG, MC ;

WEINBERG, RA .

NATURE, 1986, 319 (6050) :226-230

[3] Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer [J].

Bose, Ron ;

Kavuri, Shyam M. ;

Searleman, Adam C. ;

Shen, Wei ;

Shen, Dong ;

Koboldt, Daniel C. ;

Monsey, John ;

Goel, Nicholas ;

Aronson, Adam B. ;

Li, Shunqiang ;

Ma, Cynthia X. ;

Ding, Li ;

Mardis, Elaine R. ;

Ellis, Matthew J. .

CANCER DISCOVERY, 2013, 3 (02) :224-237

[4] Discovery of A Novel Her-1/Her-2 Dual Tyrosine Kinase Inhibitor for the Treatment of Her-1 Selective Inhibitor-Resistant Non-small Cell Lung Cancer [J].

Cha, Mi Young ;

Lee, Kwang-Ok ;

Kim, Jong Woo ;

Lee, Chang Gon ;

Song, Ji Yeon ;

Kim, Young Hoon ;

Lee, Gwan Sun ;

Park, Seung Bum ;

Kim, Maeng Sup .

JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (21) :6880-6888

[5] TYROSINE KINASE RECEPTOR WITH EXTENSIVE HOMOLOGY TO EGF RECEPTOR SHARES CHROMOSOMAL LOCATION WITH NEU ONCOGENE [J].

COUSSENS, L ;

YANGFENG, TL ;

LIAO, YC ;

CHEN, E ;

GRAY, A ;

MCGRATH, J ;

SEEBURG, PH ;

LIBERMANN, TA ;

SCHLESSINGER, J ;

FRANCKE, U ;

LEVINSON, A ;

ULLRICH, A .

SCIENCE, 1985, 230 (4730) :1132-1139

[6] Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer [J].

Goldenberg, MM .

CLINICAL THERAPEUTICS, 1999, 21 (02) :309-318

[7] ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling [J].

GrausPorta, D ;

Beerli, RR ;

Daly, JM ;

Hynes, NE .

EMBO JOURNAL, 1997, 16 (07) :1647-1655

[8] Pertuzumab: A New Targeted Therapy for HER2-Positive Metastatic Breast Cancer [J].

Malenfant, Stephanie J. ;

Eckmann, Karen R. ;

Barnett, Chad M. .

PHARMACOTHERAPY, 2014, 34 (01) :60-71

[9] Lapatinib: a dual inhibitor of EGFR and HER2 tyrosine kinase activity [J].

Montemurro, Filippo ;

Valabrega, Giorgio ;

Aglietta, Massimo .

EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (02) :257-268

[10] Lapatinib-associated toxicity and practical management recommendations [J].

Moy, Beverly ;

Goss, Paul E. .

ONCOLOGIST, 2007, 12 (07) :756-765

← 1 2 →